Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Celtrix's SomatoKine proven safe in phase I

July 26, 1996

SR-12813: SmithKline Beecham and Symphar's hypocholesterolemic drug

July 26, 1996

Patent collaboration on bone morphogenetic/osteogenetic proteins

July 26, 1996

Boehringer Mannheim reveals acatelin, a novel ACAT inhibitor

July 26, 1996

Isolation of SOX-9 polypeptide encoding gene announced

July 26, 1996

Didronel receives 22nd marketing approval

July 19, 1996

Lea's Shield demonstrates contraceptive efficacy and safety

July 19, 1996

High continuation rate demonstrated for Norplant in first year of use

July 19, 1996

Organon's Puregon more effective than traditional fertility hormone

July 19, 1996

RPR receives marketing approval for Menorest in four countries

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...